Patient-Centric Services

Expanded Access Programs

Marken transports and delivers investigational medical products that have not yet been approved by the FDA for use by patients who face a life-threatening or critical illness and who receive special exemptions for the unapproved treatments. Early access programs, also known as compassionate use, expedite the transport of these products is extremely time and temperature sensitive and often requires alternative transport solutions including, but not limited to, on-board courier and charter services, a specialized delivery by a dedicated Marken team.

Our Expanded Access Programs, also known as compassionate use, expedite the delivery of life-changing treatments.

Only Marken delivers the end-to-end capabilities and expert oversight needed to seamlessly guide your program through each stage of the pharmaceutical journey. Our experts and customer service specialists are available to discuss your API Drug Shipment requirements. Contact us on +1-800-627-5361 (US) or email info@marken.com

Related resources

Strengthening clinical logistics with a focus on the patient

27 February 2024

For over 40 years, Marken has been at the forefront of delivering time and temperature-critical pharmaceuticals and biological materials globally….

Fierce Biotech Webinar: Accelerate Your Central Lab Value Chain: Flexible Solutions to Reach Patients Faster

20 July 2023

With the ongoing complexities of clinical treatment journeys, central labs remain a vital component in the supply chain for developing…

Reshaping Decentralized Clinical Trials With Fit-For-Patient Solutions

20 June 2023

The need to rethink traditional models in recent years has led to a revolution in the way clinical trials are…

Marken: Patient-Centric Supply Chain Solutions

14 April 2023

Patient, doctor and industry interest continues to shift dramatically towards siteless and hybrid clinical trials. Marken’s comprehensive suite of patient-centric…

Light the Way Forward With Marken

13 April 2023

Each year, we are inspired by your dedication to find cures and ease conditions for patients. To continue the momentum…

Marken Delivers Lifesaving Intravenous Therapy from Pennsylvania to Sites Across the USA Within 24 Hours

9 February 2023

Marken successfully delivered the time-critical intravenous therapy, Legalon, from its GMP Philadelphia depot to sites across the USA to treat…

Marken Successfully Delivers Lifesaving Apheresis Treatment From The USA to the UK Within 24 Hours

9 February 2023

Marken was tasked with performing a next-day collection of temperature-sensitive tumor material from Philadelphia to Manchester, UK for an urgent…

Revolutionizing Patient-Centric Supply Chains to Improve Vaccine Access.

7 February 2023

Global disruptions over the past several years have had an undeniable impact on the vaccine landscape, including research trends, risk…

Happy Holidays from Marken

21 December 2022

At Marken, we are passionate about patients – always finding a way to deliver for our clients – on-time, within…

Marken Successfully Ships Lifesaving Treatments For Humanitarian Aid In Ukraine

24 June 2022

Marken successfully transported critical compassionate use medicinal products and supplies as part of a humanitarian effort in Ukraine. Mitigating the…

Patient Centricity in Clinical Trials: Solutions for the Evolving Landscape

1 March 2022

Two years into the pandemic, it’s clear that decentralized clinical trials are here to stay. Approximately 70 percent of patients…

Decentralized Trial Logistics Requires Thoughtful Strategy.

22 September 2021

Outsourcing Pharma and Marken President Ariette van Strien discuss the complexity of decentralized trials and considerations for crafting a strategic…

View more
Marken Logo

Understanding why we must adapt, continuously asking ourselves how we can change what matters is how we keep on delivering it.